200,000+ products from a single source!
sales@angenechem.com
157832-56-9 | Benzamide, N-[5-(diethylamino)-1-phenylpentyl]-4-nitro-, hydrochloride (1:1)
CAS No: 157832-56-9 Catalog No: AG001MNC MDL No:MFCD00492838
Product Description
Catalog Number:
AG001MNC
Chemical Name:
Benzamide, N-[5-(diethylamino)-1-phenylpentyl]-4-nitro-, hydrochloride (1:1)
CAS Number:
157832-56-9
Molecular Formula:
C22H30ClN3O3
Molecular Weight:
419.9449
MDL Number:
MFCD00492838
IUPAC Name:
N-[5-(diethylamino)-1-phenylpentyl]-4-nitrobenzamide;hydrochloride
InChI:
InChI=1S/C22H29N3O3.ClH/c1-3-24(4-2)17-9-8-12-21(18-10-6-5-7-11-18)23-22(26)19-13-15-20(16-14-19)25(27)28;/h5-7,10-11,13-16,21H,3-4,8-9,12,17H2,1-2H3,(H,23,26);1H
InChI Key:
CHCBAYRWJULIDW-UHFFFAOYSA-N
SMILES:
CCN(CCCCC(c1ccccc1)NC(=O)c1ccc(cc1)[N+](=O)[O-])CC.Cl
Properties
Complexity:
462
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
419.198g/mol
Formal Charge:
0
Heavy Atom Count:
29
Hydrogen Bond Acceptor Count:
4
Hydrogen Bond Donor Count:
2
Isotope Atom Count:
0
Molecular Weight:
419.95g/mol
Monoisotopic Mass:
419.198g/mol
Rotatable Bond Count:
10
Topological Polar Surface Area:
78.2A^2
Undefined Atom Stereocenter Count:
1
Undefined Bond Stereocenter Count:
0
Literature
| Title | Journal |
|---|---|
| Potential artefacts in proteome analysis of plasma of Gaucher patients due to protease abnormalities. | Clinica chimica acta; international journal of clinical chemistry 20081001 |
| [Nibentan in arresting acute atrial fibrillation: risk or benefit?]. | Terapevticheskii arkhiv 20080101 |
| [Effect of nibentan on dispersion of repolarization of ventricular myocardium in the rabbit]. | Kardiologiia 20080101 |
| [Comparative study of the electrophysiological properties of class iii medicinals (cardiocyclide, nibentan, sotalol) and evaluation of their efficacy in atrial fibrillation produced by auricular and vagal stimulation]. | Eksperimental'naia i klinicheskaia farmakologiia 20070101 |
| [The efficacy and safety of nibentan for pharmacological cardioversion in patients with persistent atrial fibrillation and flutter: the role of dose limitation and magnesium sulfate administration]. | Kardiologiia 20070101 |
| [Comparison of the efficacy and safety of electrical cardioversion and pharmacological cardioversion with nibentan in patients with persisting atrial fibrillation and flutter]. | Vestnik Rossiiskoi akademii meditsinskikh nauk 20070101 |
| [Effect of the class III antiarrhythmic drug nibentan in vagotonic atrial fibrillation]. | Eksperimental'naia i klinicheskaia farmakologiia 20060101 |
| Myocardial contractility after in vitro treatment with class III antiarrhythmic drug Nibentan. | Bulletin of experimental biology and medicine 20060101 |
| [Nibentan -- a drug for pharmacological cardioversion of persistent atrial fibrillation]. | Kardiologiia 20050101 |
| [Cardiac effects of the class III antiarrhythmic drugs amiodarone and nibentan]. | Fiziologiia cheloveka 20050101 |
| [Comparative study of electrophysiological mechanisms of anti-arrhythmia III class agents, cardiocyclide, nibentan, and sotalol during experimental myocardial infarction and sympathetic stimulation]. | Eksperimental'naia i klinicheskaia farmakologiia 20030101 |
| [Electrophysiological effects and mechanisms of antiarrhythmic action of nibentan in patients with paroxysmal arrhythmias]. | Kardiologiia 20030101 |
| [Novel antiarrhythmic class III drug nibentan: from experimental studies to clinical practice]. | Kardiologiia 20030101 |
| [Development of original Russian antiarrhythmic drugs of the 3rd class]. | Vestnik Rossiiskoi akademii meditsinskikh nauk 20030101 |
| Effect of class III antiarrhythmic preparation nibentan on extrasystolic and post-extrasystolic contraction of rat papillary muscle. | Bulletin of experimental biology and medicine 20020701 |
| [Comparative study of the anti-arrhythmic activity of cardiocyclide and nibentan in hypersympathotonia and acute myocardial ischemia]. | Eksperimental'naia i klinicheskaia farmakologiia 20020101 |
| [Effect of mexidol, emoxypine, and dimephosphon on electrophysiological effects of nibentan]. | Eksperimental'naia i klinicheskaia farmakologiia 20020101 |
| [Effect of a nibentan derivative LKhT53-91 on the heart electrophysiological parameters]. | Eksperimental'naia i klinicheskaia farmakologiia 20020101 |
| [The effect of novel class III anti-arrhythmia agents cardiocyclide and nibentan during activation of cardiac beta-adrenoreceptors]. | Eksperimental'naia i klinicheskaia farmakologiia 20020101 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.